To further confirm the roles of Kla modifications in the setting of stroke, 2‐deoxyglucose (2‐DG) and 4‐hydroxycinnamate (4‐CIN) were used to block glycolysis and lactate shuttle respectively (Figure 1D). This evidence concerns the gene KL and stroke disorder.